Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.43 is 52% below its 5-year average of 2.99, near the low end of its 5-year range (1.39–6.20).
As of the fiscal period ended Tuesday, June 30, 2026. 5.06% below its 12-month average of 1.50.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.43.
CURRENT RATIO
1.43
CURRENT RATIO AVG TTM
1.50
CURRENT RATIO AVG 3Y
2.49
CURRENT RATIO AVG 5Y
2.99
CURRENT RATIO AVG 10Y
3.97
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.06%
CURRENT VS 3Y AVG
-42.75%
CURRENT VS 5Y AVG
-52.26%
CURRENT VS 10Y AVG
-64.05%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.12
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
-54.30%
vs the sector median at left
Axsome Therapeutics, Inc.
Market Cap
$9.11B
Current Ratio
1.43
TTM Avg
1.50
3Y Avg
2.49
5Y Avg
2.99
Market Cap
$8.78B
Current Ratio
5.90
TTM Avg
5.80
3Y Avg
4.63
5Y Avg
4.84
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $9.11B | 1.43 | 1.50 | 2.49 | 2.99 |
| Bruker Corporation (BRKRP)vs › | $9.35B | 1.85 | 1.67 | 1.86 | 2.08 |
| Insulet Corp. (PODD)vs › | $9.39B | 2.48 | 3.16 | 3.34 | 4.18 |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | 5.90 | 5.80 | 4.63 | 4.84 |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 1.32 | 1.40 | 1.56 | 1.60 |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 5.53 | 4.58 | 3.87 | 3.23 |
| Bruker Corporation (BRKR)vs › | $9.72B | 1.85 | 1.67 | 1.86 | 2.08 |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 1.08 | 0.93 | 1.08 | 1.24 |
| Align Technology, Inc. (ALGN)vs › | $10.07B | 1.40 | 1.29 | 1.26 | 1.29 |
| The Ensign Group, Inc. (ENSG)vs › | $10.08B | 1.21 | 1.49 | 1.44 | 1.33 |
Current Ratio
1.43
Quick Ratio
1.34
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.43 |
| 2026-03-31 | 1.39 |
| 2025-12-31 | 1.55 |
| 2025-09-30 | 1.57 |
| 2025-06-30 | 1.57 |
| 2025-03-31 | 2.03 |
| 2024-12-31 | 2.11 |
| 2024-09-30 | 2.44 |
| 2024-06-30 | 2.48 |
| 2024-03-31 | 3.20 |
| 2023-12-31 | 3.63 |
| 2023-09-30 | 4.46 |
| 2023-06-30 | 4.52 |
| 2023-03-31 | 3.02 |
| 2022-12-31 | 2.54 |
| 2022-09-30 | 4.19 |
| 2022-06-30 | 2.44 |
| 2022-03-31 | 3.54 |
| 2021-12-31 | 3.75 |
| 2021-09-30 | 4.66 |
| 2021-06-30 | 6.20 |
| 2021-03-31 | 7.61 |
| 2020-12-31 | 7.85 |
| 2020-09-30 | 9.99 |
| 2020-06-30 | 8.30 |
| 2020-03-31 | 7.57 |
| 2019-12-31 | 9.00 |
| 2019-09-30 | 2.39 |
| 2019-06-30 | 4.18 |
| 2019-03-31 | 5.68 |
| 2018-12-31 | 1.41 |
| 2018-09-30 | 1.46 |
| 2018-06-30 | 2.26 |
| 2018-03-31 | 2.95 |
| 2017-12-31 | 2.90 |
| 2017-09-30 | 3.86 |
| 2017-06-30 | 4.73 |
| 2017-03-31 | 5.53 |
| 2016-12-31 | 5.30 |
| 2016-09-30 | 5.16 |
| 2016-06-30 | 7.82 |
| 2016-03-31 | 11.51 |
| 2015-12-31 | 18.63 |
| 2015-09-30 | 2.22 |
| 2015-06-30 | 4.36 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 2.82 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
